Literature DB >> 28396903

[Diabetes and heart failure : Update 2017].

K Schütt1, N Marx2.   

Abstract

Patients with diabetes mellitus exhibit an increased risk for the development of heart failure. The occurrence of heart failure in patients with diabetes is associated with a poor prognosis. Therapeutic strategies to reduce cardiovascular morbidity and mortality in diabetes have so far mainly focused on the prevention of coronary events but recent data suggest that an early diagnosis of heart failure in diabetes as well as specific therapies could have a major impact on the prognosis for these patients. This article aims to provide a comprehensive overview on the epidemiology, pathophysiology and prognosis of heart failure in diabetes patients and addresses current aspects of heart failure therapy in diabetes as well as diabetes therapy in heart failure patients.

Entities:  

Keywords:  Antidiabetic therapy; Diabetes mellitus; Diagnostics; Heart failure; Heart failure treatment

Mesh：

Substances：

Year:  2017        PMID： 28396903     DOI： 10.1007/s00059-017-4558-1

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  32 in total

1.  Diabetes and the heart-at the edge between upcoming solutions and newly detected problems.

Authors:  D Tschoepe; R Dörr; D Müller-Wieland
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

2.  Diabetes and the heart--a never-ending story.

Authors:  Rolf Dörr; Dirk Müller-Wieland; Diethelm Tschoepe
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

3.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

4.  Prevalence and prognostic implications of pre-diabetic state in patients with heart failure.

Authors:  Yuya Matsue; Makoto Suzuki; Rena Nakamura; Masami Abe; Maki Ono; Seigo Yoshida; Mie Seya; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Akihiko Matsumura; Yuji Hashimoto
Journal:  Circ J       Date:  2011-10-19       Impact factor: 2.993

5.  Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

6.  Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  Hossein Bahrami; David A Bluemke; Richard Kronmal; Alain G Bertoni; Donald M Lloyd-Jones; Eyal Shahar; Moyses Szklo; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-05-06       Impact factor: 24.094

7.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

8.  Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

Authors:  Ida Gustafsson; Bente Brendorp; Marie Seibaek; Hans Burchardt; Per Hildebrandt; Lars Køber; Christian Torp-Pedersen
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

9.  Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

Authors:  Shuo-Ming Ou; Chia-Jen Shih; Pei-Wen Chao; Hsi Chu; Shu-Chen Kuo; Yi-Jung Lee; Shuu-Jiun Wang; Chih-Yu Yang; Chih-Ching Lin; Tzeng-Ji Chen; Der-Cherng Tarng; Szu-Yuan Li; Yung-Tai Chen
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

10.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079
View more
  1 in total

1.  Time to Death and Its Determinant Factors Among Patients With Chronic Heart Failure in Northwest Ethiopia: A Retrospective Study at Selected Referral Hospitals.

Authors:  Yikeber Abebaw Moyehodie; Mitiku Wale Muluneh; Alebachew Taye Belay; Setegn Muche Fenta
Journal:  Front Cardiovasc Med       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.